ASSOCIATE PROF. DR. POH MAU ERN
Department of Medicine
Faculty of Medicine
ernestpohum.edu.myView CV | |
Publons | |
Biography | |
Professor Dr. Ernest Poh Mau Ern is Associate Professor of Medicine at the Faculty of Medicine, University of Malaya. He is also Consultant Respiratory Physician at both University Malaya Medical Centre (UMMC) and University Malaya Specialist Centre (UMSC). Formerly a graduate of University of Malaya, he has worked both locally and abroad in the United Kingdom being trained in areas of respiratory, critical care, transplant and sleep medicine. He is highly skillful in pleural ultrasound, bronchoscopy and pleuroscopy. Prior to his return to Malaysia, he was awarded the Specialty Certificate in Respiratory Medicine by the Royal College of Physicians (UK) and British Thoracic Society (BTS). Professor Dr. Ernest Poh is a top ranked academic in the country. He was awarded the prestigious "Best Lecturer Award" by the Faculty of Medicine, University of Malaya in 2018. He is well respected and liked by peers and his students. Aside from treating a variety of respiratory and sleep conditions, Dr. Poh is recognized as an expert in lung cancer, which remains an interest close to his heart. He is an active researcher in many international clinical research trials treating lung cancer, COPD and bronchiectasis. Recognized as a global expert in respiratory medicine, he was made a Fellow of the Royal College of Physicians, FRCP (London, UK) and a Fellow of the American College of Chest Physicians, FCCP (USA). He is also affiliated to the International Association for the Study of Lung Cancer (IASLC), European Society of Medical Oncology (ESMO), Asian Pacific Society of Respirology (APSR), Malaysian Thoracic Society (MTS), Academy of Medicine Malaysia (AM), American College of Chest Physicians (ACCP) and Royal College of Physicians (RCP, UK). As a doctor, he is known to be kind, compassionate and loving and is very popular amongst his patients. |
Publication
Finance
Project Title | Progress | Status |
---|---|---|
Lignosus Rhinocerus Tm02? As An Immunomodulatory Agent For The Treatment Of Uncontrolled Asthma And Allergic Rhinitis: A Randomised, Double Blind, Placebo-control Study |
|
end |
This information is generated from Research Grant Management System |
Airway "Resistotypes" and Clinical Outcomes in Bronchiectasis
Real-world efficacy of low dose osimertinib as second-line treatment in patients with epidermal growth factor receptor-mutated advanced non-small cell lung cancer
Does dose reduction of afatinib affect treatment outcomes of patients with <i>EGFR</i>-mutant metastatic non-small cell lung cancer in real-world clinical practice?
Methyprednisolone versus dexamethasone for severe COVID-19 infection: A retrospective comparative analysis of our early experience